Browse by Changes

Prescriber Bag

Deletions

Deletion – Item

10016E BENZATROPINE, benzatropine mesilate 2 mg/2 mL injection, 10 x 2 mL vials (Benztropine Omega)

Alterations

Alteration – Item Description

From
3489P METHOXYFLURANE, methoxyflurane 999.9 mg/g inhalation solution, 3 mL (Penthrox)
To
3489P METHOXYFLURANE, methoxyflurane 99.9% (999 mg/g) inhalation solution, 3 mL bottle (Penthrox)

General Pharmaceutical Benefits

Additions

Addition – Item

11559J CLONAZEPAM, clonazepam 500 microgram tablet, 50 (Rivotril)
11577H ERTUGLIFLOZIN, ertugliflozin 5 mg tablet, 28 (Steglatro 5)
11585R ERTUGLIFLOZIN, ertugliflozin 5 mg tablet, 28 (Steglatro 5)
11570Y ERTUGLIFLOZIN, ertugliflozin 15 mg tablet, 28 (Steglatro 15)
11571B ERTUGLIFLOZIN, ertugliflozin 15 mg tablet, 28 (Steglatro 15)
11564P ERTUGLIFLOZIN + METFORMIN, ertugliflozin 2.5 mg + metformin hydrochloride 1 g tablet, 56 (Segluromet 2.5/1000)
11581M ERTUGLIFLOZIN + METFORMIN, ertugliflozin 2.5 mg + metformin hydrochloride 1 g tablet, 56 (Segluromet 2.5/1000)
11575F ERTUGLIFLOZIN + METFORMIN, ertugliflozin 2.5 mg + metformin hydrochloride 500 mg tablet, 56 (Segluromet 2.5/500)
11584Q ERTUGLIFLOZIN + METFORMIN, ertugliflozin 2.5 mg + metformin hydrochloride 500 mg tablet, 56 (Segluromet 2.5/500)
11563N ERTUGLIFLOZIN + METFORMIN, ertugliflozin 7.5 mg + metformin hydrochloride 1 g tablet, 56 (Segluromet 7.5/1000)
11569X ERTUGLIFLOZIN + METFORMIN, ertugliflozin 7.5 mg + metformin hydrochloride 1 g tablet, 56 (Segluromet 7.5/1000)
11562M ERTUGLIFLOZIN + METFORMIN, ertugliflozin 7.5 mg + metformin hydrochloride 500 mg tablet, 56 (Segluromet 7.5/500)
11568W ERTUGLIFLOZIN + METFORMIN, ertugliflozin 7.5 mg + metformin hydrochloride 500 mg tablet, 56 (Segluromet 7.5/500)
11561L ERTUGLIFLOZIN + SITAGLIPTIN, ertugliflozin 5 mg + sitagliptin 100 mg tablet, 28 (Steglujan 5/100)
11579K ERTUGLIFLOZIN + SITAGLIPTIN, ertugliflozin 5 mg + sitagliptin 100 mg tablet, 28 (Steglujan 5/100)
11578J ERTUGLIFLOZIN + SITAGLIPTIN, ertugliflozin 15 mg + sitagliptin 100 mg tablet, 28 (Steglujan 15/100)
11583P ERTUGLIFLOZIN + SITAGLIPTIN, ertugliflozin 15 mg + sitagliptin 100 mg tablet, 28 (Steglujan 15/100)
11516D GOLIMUMAB, golimumab 50 mg/0.5 mL injection, 0.5 mL syringe (Simponi)
11521J GOLIMUMAB, golimumab 50 mg/0.5 mL injection, 0.5 mL injection device (Simponi)
11538G GOLIMUMAB, golimumab 50 mg/0.5 mL injection, 0.5 mL injection device (Simponi)
11560K GOLIMUMAB, golimumab 50 mg/0.5 mL injection, 0.5 mL syringe (Simponi)
11502J GOLIMUMAB, golimumab 100 mg/mL injection, 1 mL injection device (Simponi)
11554D MESALAZINE, mesalazine 1 g enteric tablet, 60 (Salofalk)
11525N METHOTREXATE, methotrexate 7.5 mg/0.3 mL injection, 4 x 0.3 mL syringes (Methoblastin PFS)
11526P METHOTREXATE, methotrexate 10 mg/0.4 mL injection, 4 x 0.4 mL syringes (Methoblastin PFS)
11508Q METHOTREXATE, methotrexate 15 mg/0.6 mL injection, 4 x 0.6 mL syringes (Methoblastin PFS)
11509R METHOTREXATE, methotrexate 20 mg/0.8 mL injection, 4 x 0.8 mL syringes (Methoblastin PFS)
11544N METHOTREXATE, methotrexate 25 mg/mL injection, 4 x 1 mL syringes (Methoblastin PFS)
11503K OLAPARIB, olaparib 100 mg tablet, 2 x 56 (Lynparza)
11522K OLAPARIB, olaparib 100 mg tablet, 2 x 56 (Lynparza)
11528R OLAPARIB, olaparib 150 mg tablet, 2 x 56 (Lynparza)
11539H OLAPARIB, olaparib 150 mg tablet, 2 x 56 (Lynparza)
11572C SITAGLIPTIN, sitagliptin 25 mg tablet, 28 (Januvia)
11573D SITAGLIPTIN, sitagliptin 50 mg tablet, 28 (Januvia)
11576G SITAGLIPTIN, sitagliptin 100 mg tablet, 28 (Januvia)
11586T SITAGLIPTIN + METFORMIN, sitagliptin 50 mg + metformin hydrochloride 500 mg tablet, 56 (Janumet)
11582N SITAGLIPTIN + METFORMIN, sitagliptin 50 mg + metformin hydrochloride 850 mg tablet, 56 (Janumet)
11574E SITAGLIPTIN + METFORMIN, sitagliptin 50 mg + metformin hydrochloride 1 g tablet, 56 (Janumet)
11580L SITAGLIPTIN + METFORMIN, sitagliptin 50 mg + metformin hydrochloride 1 g modified release tablet, 56 (Janumet XR)
11566R SITAGLIPTIN + METFORMIN, sitagliptin 100 mg + metformin hydrochloride 1 g tablet: modified release, 28 (Janumet XR)
11565Q TOCILIZUMAB, tocilizumab 162 mg/0.9 mL injection, 4 x 0.9 mL injection devices (Actemra ACTPen)
11567T TOCILIZUMAB, tocilizumab 162 mg/0.9 mL injection, 4 x 0.9 mL injection devices (Actemra ACTPen)
11507P TRIFLURIDINE + TIPIRACIL, trifluridine 15 mg + tipiracil 6.14 mg tablet, 20 (Lonsurf 15/6.14)
11524M TRIFLURIDINE + TIPIRACIL, trifluridine 20 mg + tipiracil 8.19 mg tablet, 20 (Lonsurf 20/8.19)

Addition – Brand

10788T Flucloxacillin GH, GQFLUCLOXACILLIN, flucloxacillin 500 mg capsule, 24
1527J Flucloxacillin GH, GQFLUCLOXACILLIN, flucloxacillin 500 mg capsule, 24
5091Y Flucloxacillin GH, GQFLUCLOXACILLIN, flucloxacillin 500 mg capsule, 24
11209Y S-26 Original Alula L.I., ASMILK POWDER LACTOSE INTOLERANCE FORMULA, milk powder lactose intolerance formula powder for oral liquid, 900 g
2348N BTC PREGABALIN, JBPREGABALIN, pregabalin 25 mg capsule, 56
2335X BTC PREGABALIN, JBPREGABALIN, pregabalin 75 mg capsule, 56
2355Y BTC PREGABALIN, JBPREGABALIN, pregabalin 150 mg capsule, 56
2363J BTC PREGABALIN, JBPREGABALIN, pregabalin 300 mg capsule, 56
2590H BTC Rosuvastatin, JBROSUVASTATIN, rosuvastatin 5 mg tablet, 30
2590H Rosuvastatin APOTEX, GXROSUVASTATIN, rosuvastatin 5 mg tablet, 30
2606E BTC Rosuvastatin, JBROSUVASTATIN, rosuvastatin 5 mg tablet, 30
2606E Rosuvastatin APOTEX, GXROSUVASTATIN, rosuvastatin 5 mg tablet, 30
2584B BTC Rosuvastatin, JBROSUVASTATIN, rosuvastatin 10 mg tablet, 30
2584B Rosuvastatin APOTEX, GXROSUVASTATIN, rosuvastatin 10 mg tablet, 30
2628H BTC Rosuvastatin, JBROSUVASTATIN, rosuvastatin 10 mg tablet, 30
2628H Rosuvastatin APOTEX, GXROSUVASTATIN, rosuvastatin 10 mg tablet, 30
2574L BTC Rosuvastatin, JBROSUVASTATIN, rosuvastatin 20 mg tablet, 30
2574L Rosuvastatin APOTEX, GXROSUVASTATIN, rosuvastatin 20 mg tablet, 30
2609H BTC Rosuvastatin, JBROSUVASTATIN, rosuvastatin 20 mg tablet, 30
2609H Rosuvastatin APOTEX, GXROSUVASTATIN, rosuvastatin 20 mg tablet, 30
2594M BTC Rosuvastatin, JBROSUVASTATIN, rosuvastatin 40 mg tablet, 30
2594M Rosuvastatin APOTEX, GXROSUVASTATIN, rosuvastatin 40 mg tablet, 30
2636R BTC Rosuvastatin, JBROSUVASTATIN, rosuvastatin 40 mg tablet, 30
2636R Rosuvastatin APOTEX, GXROSUVASTATIN, rosuvastatin 40 mg tablet, 30

Addition – Equivalence Indicator

11275K Trexject, LMMETHOTREXATE, methotrexate 7.5 mg/0.15 mL injection, 0.15 mL syringe
11283W Trexject, LMMETHOTREXATE, methotrexate 10 mg/0.2 mL injection, 0.2 mL syringe
11268C Trexject, LMMETHOTREXATE, methotrexate 15 mg/0.3 mL injection, 0.3 mL syringe
11288D Trexject, LMMETHOTREXATE, methotrexate 20 mg/0.4 mL injection, 0.4 mL syringe
11295L Trexject, LMMETHOTREXATE, methotrexate 25 mg/0.5 mL injection, 0.5 mL syringe

Addition – Note

1805B CLONAZEPAM, clonazepam 500 microgram tablet, 100 (Paxam 0.5, Rivotril)
11275K METHOTREXATE, methotrexate 7.5 mg/0.15 mL injection, 0.15 mL syringe (Trexject)
11283W METHOTREXATE, methotrexate 10 mg/0.2 mL injection, 0.2 mL syringe (Trexject)
11268C METHOTREXATE, methotrexate 15 mg/0.3 mL injection, 0.3 mL syringe (Trexject)
11288D METHOTREXATE, methotrexate 20 mg/0.4 mL injection, 0.4 mL syringe (Trexject)
11295L METHOTREXATE, methotrexate 25 mg/0.5 mL injection, 0.5 mL syringe (Trexject)

Addition – Restriction

9180E SITAGLIPTIN, sitagliptin 25 mg tablet, 28 (Januvia)
9181F SITAGLIPTIN, sitagliptin 50 mg tablet, 28 (Januvia)
9182G SITAGLIPTIN, sitagliptin 100 mg tablet, 28 (Januvia)
9449H SITAGLIPTIN + METFORMIN, sitagliptin 50 mg + metformin hydrochloride 500 mg tablet, 56 (Janumet)
9450J SITAGLIPTIN + METFORMIN, sitagliptin 50 mg + metformin hydrochloride 850 mg tablet, 56 (Janumet)
10090C SITAGLIPTIN + METFORMIN, sitagliptin 50 mg + metformin hydrochloride 1 g modified release tablet, 56 (Janumet XR)
9451K SITAGLIPTIN + METFORMIN, sitagliptin 50 mg + metformin hydrochloride 1 g tablet, 56 (Janumet)
10089B SITAGLIPTIN + METFORMIN, sitagliptin 100 mg + metformin hydrochloride 1 g tablet: modified release, 28 (Janumet XR)

Deletions

Deletion – Item

10013B BENZATROPINE, benzatropine mesilate 2 mg/2 mL injection, 10 x 2 mL vials (Benztropine Omega)
10027R BENZATROPINE, benzatropine mesilate 2 mg/2 mL injection, 10 x 2 mL vials (Benztropine Omega)

Deletion – Brand

11209Y S-26 Original LI, ASMILK POWDER LACTOSE INTOLERANCE FORMULA, milk powder lactose intolerance formula powder for oral liquid, 900 g
8378Y Temodal, MKTEMOZOLOMIDE, temozolomide 5 mg capsule, 5
8819E Temodal, MKTEMOZOLOMIDE, temozolomide 5 mg capsule, 5
8379B Temodal, MKTEMOZOLOMIDE, temozolomide 20 mg capsule, 5
8820F Temodal, MKTEMOZOLOMIDE, temozolomide 20 mg capsule, 5
9368C Dilart, AFVALSARTAN, valsartan 40 mg tablet, 28
9369D Dilart, AFVALSARTAN, valsartan 80 mg tablet, 28
9370E Dilart, AFVALSARTAN, valsartan 160 mg tablet, 28
9371F Dilart, AFVALSARTAN, valsartan 320 mg tablet, 28
9372G Dilart HCT 80/12.5, AFVALSARTAN + HYDROCHLOROTHIAZIDE, valsartan 80 mg + hydrochlorothiazide 12.5 mg tablet, 28
9373H Dilart HCT 160/12.5, AFVALSARTAN + HYDROCHLOROTHIAZIDE, valsartan 160 mg + hydrochlorothiazide 12.5 mg tablet, 28
9374J Dilart HCT 160/25, AFVALSARTAN + HYDROCHLOROTHIAZIDE, valsartan 160 mg + hydrochlorothiazide 25 mg tablet, 28
9481B Dilart HCT 320/12.5, AFVALSARTAN + HYDROCHLOROTHIAZIDE, valsartan 320 mg + hydrochlorothiazide 12.5 mg tablet, 28
9482C Dilart HCT 320/25, AFVALSARTAN + HYDROCHLOROTHIAZIDE, valsartan 320 mg + hydrochlorothiazide 25 mg tablet, 28

Deletion – Note

11382C GOLIMUMAB, golimumab 100 mg/mL injection, 1 mL injection device (Simponi)

Deletion – Restriction

11382C GOLIMUMAB, golimumab 100 mg/mL injection, 1 mL injection device (Simponi)

Alterations

Alteration – Item Description

From
8959M DALTEPARIN SODIUM, DALTEPARIN SODIUM (Low Molecular Weight Heparin Sodium-porcine mucous) Injection 15,000 units (anti-Xa) in 0.6 mL single dose pre-filled syringe, 10 (Fragmin)
To
8959M DALTEPARIN SODIUM, dalteparin sodium 15 000 anti-Xa units/0.6 mL injection, 10 x 0.6 mL syringes (Fragmin)
From
8960N DALTEPARIN SODIUM, DALTEPARIN SODIUM (Low Molecular Weight Heparin Sodium-porcine mucous) Injection 18,000 units (anti-Xa) in 0.72 mL single dose pre-filled syringe, 10 (Fragmin)
To
8960N DALTEPARIN SODIUM, dalteparin sodium 18 000 anti-Xa units/0.72 mL injection, 10 x 0.72 mL syringes (Fragmin)
From
1288T DEXAMETHASONE, DEXAMETHASONE Eye drops 1 mg per mL (0.1%), 5 mL, 1 (Maxidex)
To
1288T DEXAMETHASONE, dexamethasone 0.1% eye drops, 5 mL (Maxidex)
From
5565X DEXAMETHASONE, DEXAMETHASONE Eye drops 1 mg per mL (0.1%), 5 mL, 1 (Maxidex)
To
5565X DEXAMETHASONE, dexamethasone 0.1% eye drops, 5 mL (Maxidex)
From
1292B DEXAMETHASONE, DEXAMETHASONE Tablet 500 micrograms, 30 (Dexmethsone)
To
1292B DEXAMETHASONE, dexamethasone 500 microgram tablet, 30 (Dexmethsone)
From
2507Y DEXAMETHASONE, DEXAMETHASONE Tablet 4 mg, 30 (Dexmethsone)
To
2507Y DEXAMETHASONE, dexamethasone 4 mg tablet, 30 (Dexmethsone)
From
1291Y DEXAMETHASONE PHOSPHATE, DEXAMETHASONE SODIUM PHOSPHATE Injection equivalent to 8 mg dexamethasone phosphate in 2 mL, 5 (Dexamethasone Mylan, Hospira Pty Limited)
To
1291Y DEXAMETHASONE PHOSPHATE, dexamethasone phosphate 8 mg/2 mL injection, 5 x 2 mL vials (Dexamethasone Mylan, Hospira Pty Limited)
From
8671J IPRATROPIUM, ipratropium bromide 20 microgram/actuation inhalation: pressurised, 200 actuations (Atrovent)
To
8671J IPRATROPIUM, ipratropium bromide monohydrate 21 microgram/actuation pressurised inhalation, 200 actuations (Atrovent)
From
8218M LEVODOPA + BENSERAZIDE, LEVODOPA with BENSERAZIDE Dispersible tablet 50 mg-12.5 mg, 100 (Madopar Rapid 62.5)
To
8218M LEVODOPA + BENSERAZIDE, levodopa 50 mg + benserazide 12.5 mg dispersible tablet, 100 (Madopar Rapid 62.5)
From
8219N LEVODOPA + BENSERAZIDE, LEVODOPA with BENSERAZIDE Dispersible tablet 100 mg-25 mg, 100 (Madopar Rapid 125)
To
8219N LEVODOPA + BENSERAZIDE, levodopa 100 mg + benserazide 25 mg dispersible tablet, 100 (Madopar Rapid 125)
From
5263B METHYLPREDNISOLONE, methylprednisolone Powder for injection 40 mg (as sodium succinate), 5 (Methylpred)
To
5263B METHYLPREDNISOLONE, methylprednisolone 40 mg injection, 5 vials (Methylpred)
From
5264C METHYLPREDNISOLONE, methylprednisolone Powder for injection 1 g (as sodium succinate), 1 (Methylpred, Methylprednisolone Alphapharm, Solu-Medrol)
To
5264C METHYLPREDNISOLONE, methylprednisolone 1 g injection, 1 vial (Methylpred, Methylprednisolone Alphapharm, Solu-Medrol)
From
1309X NILOTINIB, NILOTINIB Capsule 150 mg (as hydrochloride monohydrate), 120 (Tasigna)
To
1309X NILOTINIB, nilotinib 150 mg capsule, 120 (Tasigna)
From
9171Q NILOTINIB, NILOTINIB Capsule 200 mg (as hydrochloride monohydrate), 120 (Tasigna)
To
9171Q NILOTINIB, nilotinib 200 mg capsule, 120 (Tasigna)
From
1952R RASAGILINE, RASAGILINE Tablet 1 mg (as mesilate), 30 (Azilect)
To
1952R RASAGILINE, rasagiline 1 mg tablet, 30 (Azilect)
From
8972F RISEDRONATE, RISEDRONATE SODIUM Tablet 35 mg (enteric coated), 4 (Actonel EC)
To
8972F RISEDRONATE, risedronate sodium 35 mg enteric tablet, 4 (Actonel EC)

Alteration – Note

9033K ADALIMUMAB, adalimumab 40 mg/0.8 mL injection, 2 x 0.8 mL syringes (Humira)
9034L ADALIMUMAB, adalimumab 40 mg/0.8 mL injection, 2 x 0.8 mL syringes (Humira)
9101B ADALIMUMAB, adalimumab 40 mg/0.8 mL injection, 2 x 0.8 mL cartridges (Humira)
9102C ADALIMUMAB, adalimumab 40 mg/0.8 mL injection, 2 x 0.8 mL cartridges (Humira)
10238W CERTOLIZUMAB PEGOL, certolizumab pegol 200 mg/mL injection, 2 x 1 mL syringes (Cimzia)
10896L CERTOLIZUMAB PEGOL, certolizumab pegol 200 mg/mL injection, 2 x 1 mL syringes (Cimzia)
10909E CERTOLIZUMAB PEGOL, certolizumab pegol 200 mg/mL injection, 2 x 1 mL syringes (Cimzia)
11323Y CERTOLIZUMAB PEGOL, certolizumab pegol 200 mg/mL injection, 2 x 1 mL injection devices (Cimzia)
11324B CERTOLIZUMAB PEGOL, certolizumab pegol 200 mg/mL injection, 2 x 1 mL injection devices (Cimzia)
11326D CERTOLIZUMAB PEGOL, certolizumab pegol 200 mg/mL injection, 2 x 1 mL injection devices (Cimzia)
11207W ETANERCEPT, etanercept 25 mg injection [4 vials] (&) inert substance diluent [4 x 1 mL syringes], 1 pack (Enbrel)
9035M ETANERCEPT, etanercept 25 mg injection [4 vials] (&) inert substance diluent [4 x 1 mL syringes], 1 pack (Enbrel)
9036N ETANERCEPT, etanercept 25 mg injection [4 vials] (&) inert substance diluent [4 x 1 mL syringes], 1 pack (Enbrel)
11198J ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL injection devices (Enbrel)
11202N ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL injection devices (Brenzys)
9457R ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL injection devices (Brenzys, Enbrel)
9458T ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL injection devices (Brenzys, Enbrel)
11208X ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL syringes (Enbrel)
11216H ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL syringes (Brenzys)
9087G ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL syringes (Brenzys, Enbrel)
9088H ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL syringes (Brenzys, Enbrel)
11365E GOLIMUMAB, golimumab 50 mg/0.5 mL injection, 0.5 mL injection device (Simponi)
11373N GOLIMUMAB, golimumab 50 mg/0.5 mL injection, 0.5 mL injection device (Simponi)
10894J SECUKINUMAB, secukinumab 150 mg/mL injection, 2 x 1 mL injection devices (Cosentyx)
10895K SECUKINUMAB, secukinumab 150 mg/mL injection, 1 mL injection device (Cosentyx)
10898N SECUKINUMAB, secukinumab 150 mg/mL injection, 1 mL injection device (Cosentyx)
10899P SECUKINUMAB, secukinumab 150 mg/mL injection, 2 x 1 mL injection devices (Cosentyx)
10900Q SECUKINUMAB, secukinumab 150 mg/mL injection, 1 mL injection device (Cosentyx)
10901R SECUKINUMAB, secukinumab 150 mg/mL injection, 2 x 1 mL injection devices (Cosentyx)
9180E SITAGLIPTIN, sitagliptin 25 mg tablet, 28 (Januvia)
9181F SITAGLIPTIN, sitagliptin 50 mg tablet, 28 (Januvia)
9182G SITAGLIPTIN, sitagliptin 100 mg tablet, 28 (Januvia)
9449H SITAGLIPTIN + METFORMIN, sitagliptin 50 mg + metformin hydrochloride 500 mg tablet, 56 (Janumet)
9450J SITAGLIPTIN + METFORMIN, sitagliptin 50 mg + metformin hydrochloride 850 mg tablet, 56 (Janumet)
10090C SITAGLIPTIN + METFORMIN, sitagliptin 50 mg + metformin hydrochloride 1 g modified release tablet, 56 (Janumet XR)
9451K SITAGLIPTIN + METFORMIN, sitagliptin 50 mg + metformin hydrochloride 1 g tablet, 56 (Janumet)
10089B SITAGLIPTIN + METFORMIN, sitagliptin 100 mg + metformin hydrochloride 1 g tablet: modified release, 28 (Janumet XR)
10951J TOCILIZUMAB, tocilizumab 162 mg/0.9 mL injection, 4 x 0.9 mL syringes (Actemra Subcutaneous Injection)
10954M TOCILIZUMAB, tocilizumab 162 mg/0.9 mL injection, 4 x 0.9 mL syringes (Actemra Subcutaneous Injection)
10767Q USTEKINUMAB, ustekinumab 45 mg/0.5 mL injection, 0.5 mL vial (Stelara)
10774C USTEKINUMAB, ustekinumab 45 mg/0.5 mL injection, 0.5 mL vial (Stelara)

Alteration – Restriction

10895K SECUKINUMAB, secukinumab 150 mg/mL injection, 1 mL injection device (Cosentyx)
10899P SECUKINUMAB, secukinumab 150 mg/mL injection, 2 x 1 mL injection devices (Cosentyx)
10951J TOCILIZUMAB, tocilizumab 162 mg/0.9 mL injection, 4 x 0.9 mL syringes (Actemra Subcutaneous Injection)
10954M TOCILIZUMAB, tocilizumab 162 mg/0.9 mL injection, 4 x 0.9 mL syringes (Actemra Subcutaneous Injection)

Alteration – Manufacturer Code

From To
1214X Aspen Pharma Pty LtdCODEINE, codeine phosphate hemihydrate 30 mg tablet, 20 FM QA
5063L Aspen Pharma Pty LtdCODEINE, codeine phosphate hemihydrate 30 mg tablet, 20 FM QA

Alteration – Maximum Quantity

From To
11382C GOLIMUMAB, golimumab 100 mg/mL injection, 1 mL injection device (Simponi) 1 3

Alteration – Number of Repeats

From To
11382C GOLIMUMAB, golimumab 100 mg/mL injection, 1 mL injection device (Simponi) 4 0

Advance Notices

1 January 2019

Deletion – Brand

1695F Adalat 20, BNNIFEDIPINE, nifedipine 20 mg tablet, 60
8622T Pritor Plus 40/12.5 mg, FITELMISARTAN + HYDROCHLOROTHIAZIDE, telmisartan 40 mg + hydrochlorothiazide 12.5 mg tablet, 28
8623W Pritor Plus 80/12.5 mg, FITELMISARTAN + HYDROCHLOROTHIAZIDE, telmisartan 80 mg + hydrochlorothiazide 12.5 mg tablet, 28
9381R Pritor Plus 80/25 mg, FITELMISARTAN + HYDROCHLOROTHIAZIDE, telmisartan 80 mg + hydrochlorothiazide 25 mg tablet, 28

1 February 2019

Deletion – Brand

8726G Copaxone, TBGLATIRAMER ACETATE, glatiramer acetate 20 mg/mL injection, 28 x 1 mL syringes
8010N Nitro-Dur 5, MKGLYCERYL TRINITRATE, glyceryl trinitrate 5 mg/24 hours patch, 30
8011P Nitro-Dur 10, MKGLYCERYL TRINITRATE, glyceryl trinitrate 10 mg/24 hours patch, 30
8026K Nitro-Dur 15, MKGLYCERYL TRINITRATE, glyceryl trinitrate 15 mg/24 hours patch, 30
10359F PKU Glytactin RTD 10, QHGLYCOMACROPEPTIDE AND ESSENTIAL AMINO ACIDS WITH VITAMINS AND MINERALS, glycomacropeptide and essential amino acids with vitamins and minerals containing 10 g of protein equivalent oral liquid, 30 x 250 mL cartons
2696X Camino Pro Complete, QHGLYCOMACROPEPTIDE AND ESSENTIAL AMINO ACIDS WITH VITAMINS AND MINERALS, glycomacropeptide and essential amino acids with vitamins and minerals bar, 7 x 54 g
2448W Zavedos, PFIDARUBICIN, idarubicin hydrochloride 10 mg capsule, 1
1694E Adalat 10, BNNIFEDIPINE, nifedipine 10 mg tablet, 60
10766P Viekira Pak, VEPARITAPREVIR + RITONAVIR + OMBITASVIR & DASABUVIR, paritaprevir 75 mg + ritonavir 50 mg + ombitasvir 12.5 mg tablet [56] (&) dasabuvir 250 mg tablet [56], 4 x 28
10747P Viekira Pak-RBV, VEPARITAPREVIR + RITONAVIR + OMBITASVIR & DASABUVIR & RIBAVIRIN, paritaprevir 75 mg + ritonavir 50 mg + ombitasvir 12.5 mg tablet [56] (&) dasabuvir 250 mg tablet [56] (&) ribavirin 600 mg tablet [56], 1 pack
10769T Viekira Pak-RBV, VEPARITAPREVIR + RITONAVIR + OMBITASVIR & DASABUVIR & RIBAVIRIN, paritaprevir 75 mg + ritonavir 50 mg + ombitasvir 12.5 mg tablet [56] (&) dasabuvir 250 mg tablet [56] (&) ribavirin 600 mg tablet [56], 1 pack
10771X Viekira Pak-RBV, VEPARITAPREVIR + RITONAVIR + OMBITASVIR & DASABUVIR & RIBAVIRIN, paritaprevir 75 mg + ritonavir 50 mg + ombitasvir 12.5 mg tablet [56] (&) dasabuvir 250 mg tablet [56] (&) ribavirin 200 mg tablet [168], 1 pack
10772Y Viekira Pak-RBV, VEPARITAPREVIR + RITONAVIR + OMBITASVIR & DASABUVIR & RIBAVIRIN, paritaprevir 75 mg + ritonavir 50 mg + ombitasvir 12.5 mg tablet [56] (&) dasabuvir 250 mg tablet [56] (&) ribavirin 200 mg tablet [168], 1 pack
8444K Gelofusine, BRSUCCINYLATED GELATIN, succinylated gelatin 20 g/500 mL injection, 500 mL bag

1 March 2019

Deletion – Brand

1002R Zovirax, GKACICLOVIR, aciclovir 3% eye ointment, 4.5 g
5501M Zovirax, GKACICLOVIR, aciclovir 3% eye ointment, 4.5 g
2738D XP Maxamaid, SBAMINO ACID FORMULA WITH VITAMINS AND MINERALS WITHOUT PHENYLALANINE, amino acid formula with vitamins and minerals without phenylalanine powder for oral liquid, 500 g

1 April 2019

Deletion – Brand

8362D Xeloda, ROCAPECITABINE, capecitabine 500 mg tablet, 120
5132D Dilaudid, MFHYDROMORPHONE, hydromorphone hydrochloride 1 mg/mL oral liquid, 473 mL
8424J Dilaudid, MFHYDROMORPHONE, hydromorphone hydrochloride 1 mg/mL oral liquid, 473 mL

1 September 2019

Deletion – Brand

1711C Hypurin Isophane, ASINSULIN ISOPHANE BOVINE, insulin isophane bovine 100 units/mL injection, 1 x 10 mL vial
1713E Hypurin Neutral, ASINSULIN NEUTRAL BOVINE, insulin neutral bovine 100 units/mL injection, 1 x 10 mL vial

Palliative Care

Additions

Addition – Item

11520H CLONAZEPAM, clonazepam 500 microgram tablet, 50 (Rivotril)

Addition – Note

5337X CLONAZEPAM, clonazepam 500 microgram tablet, 100 (Paxam 0.5, Rivotril)

Alterations

Alteration – Item Description

From
5424L METHYLNALTREXONE, METHYLNALTREXONE Solution for injection containing methylnaltrexone bromide 12 mg in 0.6 mL, 7 (Relistor)
To
5424L METHYLNALTREXONE, methylnaltrexone bromide 12 mg/0.6 mL injection, 7 x 0.6 mL vials (Relistor)

Highly Specialised Drugs Program (Private Hospital)

Additions

Addition – Item

11504L BENRALIZUMAB, benralizumab 30 mg/mL injection, 1 mL syringe (Fasenra)
11523L BENRALIZUMAB, benralizumab 30 mg/mL injection, 1 mL syringe (Fasenra)
11545P DEFERASIROX, deferasirox 90 mg tablet, 30 (Jadenu)
11548T DEFERASIROX, deferasirox 90 mg tablet, 30 (Jadenu)
11558H DEFERASIROX, deferasirox 90 mg tablet, 30 (Jadenu)
11510T DEFERASIROX, deferasirox 180 mg tablet, 30 (Jadenu)
11546Q DEFERASIROX, deferasirox 180 mg tablet, 30 (Jadenu)
11557G DEFERASIROX, deferasirox 180 mg tablet, 30 (Jadenu)
11496C DEFERASIROX, deferasirox 360 mg tablet, 30 (Jadenu)
11511W DEFERASIROX, deferasirox 360 mg tablet, 30 (Jadenu)
11547R DEFERASIROX, deferasirox 360 mg tablet, 30 (Jadenu)
11498E INFLIXIMAB, infliximab 100 mg injection, 1 vial (Remicade)
11515C INFLIXIMAB, infliximab 100 mg injection, 1 vial (Inflectra, Renflexis)
11527Q LANREOTIDE, lanreotide 120 mg/0.5 mL injection, 0.5 mL syringe (Somatuline Autogel)
11517E LENOGRASTIM, lenograstim 13.4 million units (105 microgram) injection, 1 vial (Granocyte 13)
11530W LENOGRASTIM, lenograstim 33.6 million units (263 microgram) injection, 1 vial (Granocyte 34)
11506N MIDOSTAURIN, midostaurin 25 mg capsule, 56 (Rydapt)
11518F MIDOSTAURIN, midostaurin 25 mg capsule, 112 (Rydapt)
11531X MIDOSTAURIN, midostaurin 25 mg capsule, 112 (Rydapt)
11541K MIDOSTAURIN, midostaurin 25 mg capsule, 112 (Rydapt)

Addition – Note

11236J DEFERASIROX, deferasirox 125 mg dispersible tablet, 28 (Exjade)
11241P DEFERASIROX, deferasirox 125 mg dispersible tablet, 28 (Exjade)
6499C DEFERASIROX, deferasirox 125 mg dispersible tablet, 28 (Exjade)
11238L DEFERASIROX, deferasirox 250 mg dispersible tablet, 28 (Exjade)
11244T DEFERASIROX, deferasirox 250 mg dispersible tablet, 28 (Exjade)
6500D DEFERASIROX, deferasirox 250 mg dispersible tablet, 28 (Exjade)
11232E DEFERASIROX, deferasirox 500 mg dispersible tablet, 28 (Exjade)
11243R DEFERASIROX, deferasirox 500 mg dispersible tablet, 28 (Exjade)
9600G DEFERASIROX, deferasirox 500 mg dispersible tablet, 28 (Exjade)

Deletions

Deletion – Item

6337M LENOGRASTIM, LENOGRASTIM Powder for injection 13,400,000 i.u. (105 micrograms) vial, 10 (Granocyte 13)
6338N LENOGRASTIM, LENOGRASTIM Powder for injection 33,600,000 i.u. (263 micrograms) vial, 10 (Granocyte 34)

Alterations

Alteration – Item Description

From
2008Q MANNITOL, MANNITOL Pack containing 280 capsules containing powder for inhalation 40 mg and 2 inhalers, 1 (bronchitol)
To
2008Q MANNITOL, mannitol 40 mg powder for inhalation, 280 capsules (bronchitol)

Alteration – Note

6496X INFLIXIMAB, infliximab 100 mg injection, 1 vial (Inflectra, Remicade, Renflexis)
11003D MEPOLIZUMAB, mepolizumab 100 mg injection, 1 vial (Nucala)
11014Q MEPOLIZUMAB, mepolizumab 100 mg injection, 1 vial (Nucala)
10110D OMALIZUMAB, omalizumab 75 mg/0.5 mL injection, 0.5 mL syringe (Xolair)
10122R OMALIZUMAB, omalizumab 150 mg/mL injection, 1 mL syringe (Xolair)

Alteration – Restriction

5830W FILGRASTIM, filgrastim 120 microgram/0.2 mL injection, 10 x 0.2 mL syringes (Nivestim)
2747N FILGRASTIM, filgrastim 300 microgram/0.5 mL injection, 5 x 0.5 mL syringes (Zarzio)
9693E FILGRASTIM, filgrastim 300 microgram/0.5 mL injection, 10 x 0.5 mL syringes (Nivestim)
2733W FILGRASTIM, filgrastim 480 microgram/0.5 mL injection, 5 x 0.5 mL syringes (Zarzio)
9695G FILGRASTIM, filgrastim 480 microgram/0.5 mL injection, 10 x 0.5 mL syringes (Nivestim)
6496X INFLIXIMAB, infliximab 100 mg injection, 1 vial (Inflectra, Remicade, Renflexis)
11003D MEPOLIZUMAB, mepolizumab 100 mg injection, 1 vial (Nucala)
11014Q MEPOLIZUMAB, mepolizumab 100 mg injection, 1 vial (Nucala)
6227R OCTREOTIDE, octreotide 50 microgram/mL injection, 5 x 1 mL ampoules (Hospira Pty Limited, Octreotide (SUN), Octreotide MaxRx, Sandostatin 0.05)
6228T OCTREOTIDE, octreotide 100 microgram/mL injection, 5 x 1 mL ampoules (Hospira Pty Limited, Octreotide (SUN), Octreotide MaxRx, Sandostatin 0.1)
6229W OCTREOTIDE, octreotide 500 microgram/mL injection, 5 x 1 mL ampoules (Hospira Pty Limited, Octreotide (SUN), Octreotide MaxRx, Sandostatin 0.5)
10566D OCTREOTIDE, octreotide 10 mg injection: modified release [1 vial] (&) inert substance diluent [2 mL syringe], 1 pack (Sandostatin LAR)
10549F OCTREOTIDE, octreotide 20 mg injection: modified release [1 vial] (&) inert substance diluent [2 mL syringe], 1 pack (Sandostatin LAR)
10558Q OCTREOTIDE, octreotide 30 mg injection: modified release [1 vial] (&) inert substance diluent [2 mL syringe], 1 pack (Sandostatin LAR)
10110D OMALIZUMAB, omalizumab 75 mg/0.5 mL injection, 0.5 mL syringe (Xolair)
10122R OMALIZUMAB, omalizumab 150 mg/mL injection, 1 mL syringe (Xolair)

Advance Notices

1 February 2019

Deletion – Brand

10749R Viekira Pak, VEPARITAPREVIR + RITONAVIR + OMBITASVIR & DASABUVIR, paritaprevir 75 mg + ritonavir 50 mg + ombitasvir 12.5 mg tablet [56] (&) dasabuvir 250 mg tablet [56], 4 x 28
10750T Viekira Pak-RBV, VEPARITAPREVIR + RITONAVIR + OMBITASVIR & DASABUVIR & RIBAVIRIN, paritaprevir 75 mg + ritonavir 50 mg + ombitasvir 12.5 mg tablet [56] (&) dasabuvir 250 mg tablet [56] (&) ribavirin 600 mg tablet [56], 1 pack
10753Y Viekira Pak-RBV, VEPARITAPREVIR + RITONAVIR + OMBITASVIR & DASABUVIR & RIBAVIRIN, paritaprevir 75 mg + ritonavir 50 mg + ombitasvir 12.5 mg tablet [56] (&) dasabuvir 250 mg tablet [56] (&) ribavirin 200 mg tablet [168], 1 pack
10761J Viekira Pak-RBV, VEPARITAPREVIR + RITONAVIR + OMBITASVIR & DASABUVIR & RIBAVIRIN, paritaprevir 75 mg + ritonavir 50 mg + ombitasvir 12.5 mg tablet [56] (&) dasabuvir 250 mg tablet [56] (&) ribavirin 200 mg tablet [168], 1 pack
10773B Viekira Pak-RBV, VEPARITAPREVIR + RITONAVIR + OMBITASVIR & DASABUVIR & RIBAVIRIN, paritaprevir 75 mg + ritonavir 50 mg + ombitasvir 12.5 mg tablet [56] (&) dasabuvir 250 mg tablet [56] (&) ribavirin 600 mg tablet [56], 1 pack

Highly Specialised Drugs Program (Public Hospital)

Additions

Addition – Item

11529T BENRALIZUMAB, benralizumab 30 mg/mL injection, 1 mL syringe (Fasenra)
11549W BENRALIZUMAB, benralizumab 30 mg/mL injection, 1 mL syringe (Fasenra)
11499F DEFERASIROX, deferasirox 90 mg tablet, 30 (Jadenu)
11519G DEFERASIROX, deferasirox 90 mg tablet, 30 (Jadenu)
11534C DEFERASIROX, deferasirox 90 mg tablet, 30 (Jadenu)
11500G DEFERASIROX, deferasirox 180 mg tablet, 30 (Jadenu)
11535D DEFERASIROX, deferasirox 180 mg tablet, 30 (Jadenu)
11556F DEFERASIROX, deferasirox 180 mg tablet, 30 (Jadenu)
11533B DEFERASIROX, deferasirox 360 mg tablet, 30 (Jadenu)
11536E DEFERASIROX, deferasirox 360 mg tablet, 30 (Jadenu)
11555E DEFERASIROX, deferasirox 360 mg tablet, 30 (Jadenu)
11497D INFLIXIMAB, infliximab 100 mg injection, 1 vial (Remicade)
11514B INFLIXIMAB, infliximab 100 mg injection, 1 vial (Inflectra, Renflexis)
11513Y LANREOTIDE, lanreotide 120 mg/0.5 mL injection, 0.5 mL syringe (Somatuline Autogel)
11550X LENOGRASTIM, lenograstim 13.4 million units (105 microgram) injection, 1 vial (Granocyte 13)
11551Y LENOGRASTIM, lenograstim 33.6 million units (263 microgram) injection, 1 vial (Granocyte 34)
11505M MIDOSTAURIN, midostaurin 25 mg capsule, 112 (Rydapt)
11542L MIDOSTAURIN, midostaurin 25 mg capsule, 112 (Rydapt)
11552B MIDOSTAURIN, midostaurin 25 mg capsule, 112 (Rydapt)
11553C MIDOSTAURIN, midostaurin 25 mg capsule, 56 (Rydapt)

Addition – Note

11235H DEFERASIROX, deferasirox 125 mg dispersible tablet, 28 (Exjade)
11247Y DEFERASIROX, deferasirox 125 mg dispersible tablet, 28 (Exjade)
5654N DEFERASIROX, deferasirox 125 mg dispersible tablet, 28 (Exjade)
11239M DEFERASIROX, deferasirox 250 mg dispersible tablet, 28 (Exjade)
11240N DEFERASIROX, deferasirox 250 mg dispersible tablet, 28 (Exjade)
5655P DEFERASIROX, deferasirox 250 mg dispersible tablet, 28 (Exjade)
11231D DEFERASIROX, deferasirox 500 mg dispersible tablet, 28 (Exjade)
11234G DEFERASIROX, deferasirox 500 mg dispersible tablet, 28 (Exjade)
5656Q DEFERASIROX, deferasirox 500 mg dispersible tablet, 28 (Exjade)

Deletions

Deletion – Item

5787N LENOGRASTIM, LENOGRASTIM Powder for injection 13,400,000 i.u. (105 micrograms) vial, 10 (Granocyte 13)
5788P LENOGRASTIM, LENOGRASTIM Powder for injection 33,600,000 i.u. (263 micrograms) vial, 10 (Granocyte 34)

Alterations

Alteration – Item Description

From
2015C MANNITOL, MANNITOL Pack containing 280 capsules containing powder for inhalation 40 mg and 2 inhalers, 1 (bronchitol)
To
2015C MANNITOL, mannitol 40 mg powder for inhalation, 280 capsules (bronchitol)

Alteration – Note

5756Y INFLIXIMAB, infliximab 100 mg injection, 1 vial (Inflectra, Remicade, Renflexis)
10980X MEPOLIZUMAB, mepolizumab 100 mg injection, 1 vial (Nucala)
10996R MEPOLIZUMAB, mepolizumab 100 mg injection, 1 vial (Nucala)
10118M OMALIZUMAB, omalizumab 75 mg/0.5 mL injection, 0.5 mL syringe (Xolair)
10109C OMALIZUMAB, omalizumab 150 mg/mL injection, 1 mL syringe (Xolair)

Alteration – Restriction

5829T FILGRASTIM, filgrastim 120 microgram/0.2 mL injection, 10 x 0.2 mL syringes (Nivestim)
2758E FILGRASTIM, filgrastim 300 microgram/0.5 mL injection, 5 x 0.5 mL syringes (Zarzio)
9692D FILGRASTIM, filgrastim 300 microgram/0.5 mL injection, 10 x 0.5 mL syringes (Nivestim)
2783L FILGRASTIM, filgrastim 480 microgram/0.5 mL injection, 5 x 0.5 mL syringes (Zarzio)
9694F FILGRASTIM, filgrastim 480 microgram/0.5 mL injection, 10 x 0.5 mL syringes (Nivestim)
5756Y INFLIXIMAB, infliximab 100 mg injection, 1 vial (Inflectra, Remicade, Renflexis)
10980X MEPOLIZUMAB, mepolizumab 100 mg injection, 1 vial (Nucala)
10996R MEPOLIZUMAB, mepolizumab 100 mg injection, 1 vial (Nucala)
9508K OCTREOTIDE, octreotide 50 microgram/mL injection, 5 x 1 mL ampoules (Hospira Pty Limited, Octreotide (SUN), Octreotide MaxRx, Sandostatin 0.05)
9509L OCTREOTIDE, octreotide 100 microgram/mL injection, 5 x 1 mL ampoules (Hospira Pty Limited, Octreotide (SUN), Octreotide MaxRx, Sandostatin 0.1)
9510M OCTREOTIDE, octreotide 500 microgram/mL injection, 5 x 1 mL ampoules (Hospira Pty Limited, Octreotide (SUN), Octreotide MaxRx, Sandostatin 0.5)
10543X OCTREOTIDE, octreotide 10 mg injection: modified release [1 vial] (&) inert substance diluent [2 mL syringe], 1 pack (Sandostatin LAR)
10533J OCTREOTIDE, octreotide 20 mg injection: modified release [1 vial] (&) inert substance diluent [2 mL syringe], 1 pack (Sandostatin LAR)
10550G OCTREOTIDE, octreotide 30 mg injection: modified release [1 vial] (&) inert substance diluent [2 mL syringe], 1 pack (Sandostatin LAR)
10118M OMALIZUMAB, omalizumab 75 mg/0.5 mL injection, 0.5 mL syringe (Xolair)
10109C OMALIZUMAB, omalizumab 150 mg/mL injection, 1 mL syringe (Xolair)

Advance Notices

1 February 2019

Deletion – Brand

10751W Viekira Pak, VEPARITAPREVIR + RITONAVIR + OMBITASVIR & DASABUVIR, paritaprevir 75 mg + ritonavir 50 mg + ombitasvir 12.5 mg tablet [56] (&) dasabuvir 250 mg tablet [56], 4 x 28
10752X Viekira Pak-RBV, VEPARITAPREVIR + RITONAVIR + OMBITASVIR & DASABUVIR & RIBAVIRIN, paritaprevir 75 mg + ritonavir 50 mg + ombitasvir 12.5 mg tablet [56] (&) dasabuvir 250 mg tablet [56] (&) ribavirin 200 mg tablet [168], 1 pack
10754B Viekira Pak-RBV, VEPARITAPREVIR + RITONAVIR + OMBITASVIR & DASABUVIR & RIBAVIRIN, paritaprevir 75 mg + ritonavir 50 mg + ombitasvir 12.5 mg tablet [56] (&) dasabuvir 250 mg tablet [56] (&) ribavirin 600 mg tablet [56], 1 pack
10765N Viekira Pak-RBV, VEPARITAPREVIR + RITONAVIR + OMBITASVIR & DASABUVIR & RIBAVIRIN, paritaprevir 75 mg + ritonavir 50 mg + ombitasvir 12.5 mg tablet [56] (&) dasabuvir 250 mg tablet [56] (&) ribavirin 200 mg tablet [168], 1 pack
10768R Viekira Pak-RBV, VEPARITAPREVIR + RITONAVIR + OMBITASVIR & DASABUVIR & RIBAVIRIN, paritaprevir 75 mg + ritonavir 50 mg + ombitasvir 12.5 mg tablet [56] (&) dasabuvir 250 mg tablet [56] (&) ribavirin 600 mg tablet [56], 1 pack

Highly Specialised Drugs Program (Community Access)

Additions

Addition – Item

11540J DOLUTEGRAVIR + RILPIVIRINE, dolutegravir 50 mg + rilpivirine 25 mg tablet, 30 (Juluca)
11501H OCTREOTIDE, octreotide 10 mg injection: modified release [1 vial] (&) inert substance diluent [2 mL syringe], 1 pack (Sandostatin LAR)
11537F OCTREOTIDE, octreotide 20 mg injection: modified release [1 vial] (&) inert substance diluent [2 mL syringe], 1 pack (Sandostatin LAR)
11512X OCTREOTIDE, octreotide 30 mg injection: modified release [1 vial] (&) inert substance diluent [2 mL syringe], 1 pack (Sandostatin LAR)

Addition – Brand

10357D ABACAVIR/LAMIVUDINE 600/300 SUN, RAABACAVIR + LAMIVUDINE, abacavir 600 mg + lamivudine 300 mg tablet, 30
 

Growth Hormone Program

Additions

Addition – Item

11491T SOMATROPIN, somatropin 12 mg injection [1 cartridge] (&) inert substance diluent [1 mL cartridge], 1 pack (Genotropin)
11493X SOMATROPIN, SOMATROPIN (Recombinant human growth hormone) Powder for injection 5 mg (15 i.u.) with diluent in pre-filled pen (with preservative), 1 (Genotropin GoQuick)
11495B SOMATROPIN, SOMATROPIN (Recombinant human growth hormone) Powder for injection 12 mg (36 i.u.) with diluent in pre-filled pen (with preservative), 1 (Genotropin GoQuick)

Advance Notices

1 January 2019

Deletion – Brand

10444Q Genotropin, PFSOMATROPIN, somatropin 12 mg injection [1 cartridge] (&) inert substance diluent [1 mL cartridge], 1 pack
10499N Genotropin, PFSOMATROPIN, somatropin 12 mg injection [1 cartridge] (&) inert substance diluent [1 mL cartridge], 1 pack
6312F Genotropin, PFSOMATROPIN, somatropin 12 mg injection [1 cartridge] (&) inert substance diluent [1 mL cartridge], 1 pack
 

Repatriation Pharmaceutical Benefits

Additions

Addition – Brand

4115N ZITHRO, RFAZITHROMYCIN, azithromycin 500 mg tablet, 3
4321K Amcal Mag-A, IGMAGNESIUM ASPARTATE DIHYDRATE, magnesium aspartate dihydrate 500 mg (magnesium 37.4 mg) tablet, 50
4321K Pharmacy Care Magnesium, SIMAGNESIUM ASPARTATE DIHYDRATE, magnesium aspartate dihydrate 500 mg (magnesium 37.4 mg) tablet, 50
4522B Imoclone, RWZOPICLONE, zopiclone 7.5 mg tablet, 30

Deletions

Deletion – Item

4551M DIMETICONE-350 + GLYCEROL, dimeticone-350 15% + glycerol 2% cream, 500 g (Silic 15)
4556T DIMETICONE-350 + GLYCEROL, dimeticone-350 15% + glycerol 2% cream, 75 g (Silic 15)

Deletion – Brand

4233T Finasteride Alphapharm, AFFINASTERIDE, finasteride 5 mg tablet, 30
4071G Duro-Tuss, ILPHOLCODINE, pholcodine 1 mg/mL oral liquid, 100 mL

Alterations

Alteration – Item Description

From
4281H ICHTHAMMOL, ichthammol Cream 5 mg-10 mg-10 mg per g (0.5%-1%-1%), 50 g, 1 (Egoderm Cream)
To
4281H ICHTHAMMOL, ichthammol 1% cream, 50 g (Egoderm Cream)
From
2191H RISEDRONATE, RISEDRONATE SODIUM Tablet 35 mg (enteric coated), 4 (Actonel EC)
To
2191H RISEDRONATE, risedronate sodium 35 mg enteric tablet, 4 (Actonel EC)
 

Efficient Funding of Chemotherapy (Private Hospital)

Additions

Addition – Item

11532Y NIVOLUMAB,
nivolumab 40 mg/4 mL injection, 4 mL vial (Opdivo);
nivolumab 100 mg/10 mL injection, 10 mL vial (Opdivo)

Addition – Brand

7247K Zavedos Solution, PFIDARUBICIN, idarubicin hydrochloride 5 mg/5 mL injection, 5 mL vial
7247K Zavedos Solution, PFIDARUBICIN, idarubicin hydrochloride 10 mg/10 mL injection, 10 mL vial
7249M IRINOTECAN ACT, JUIRINOTECAN, irinotecan hydrochloride trihydrate 100 mg/5 mL injection, 5 mL vial

Addition – Caution

2638W IPILIMUMAB,
ipilimumab 50 mg/10 mL injection, 10 mL vial (Yervoy);
ipilimumab 200 mg/40 mL injection, 40 mL vial (Yervoy)

Addition – Restriction

2638W IPILIMUMAB,
ipilimumab 50 mg/10 mL injection, 10 mL vial (Yervoy);
ipilimumab 200 mg/40 mL injection, 40 mL vial (Yervoy)
10748Q NIVOLUMAB,
nivolumab 40 mg/4 mL injection, 4 mL vial (Opdivo);
nivolumab 100 mg/10 mL injection, 10 mL vial (Opdivo)

Deletions

Deletion – Brand

7247K Zavedos Solution, PFIDARUBICIN, IDARUBICIN HYDROCHLORIDE Solution for I.V. injection 5 mg in 5 mL, 3
7247K Zavedos Solution, PFIDARUBICIN, IDARUBICIN HYDROCHLORIDE Solution for I.V. injection 10 mg in 10 mL, 6

Deletion – Note

10140Q ERIBULIN,
eribulin mesilate 1 mg/2 mL injection, 2 mL vial (Halaven)
11199K ERIBULIN,
eribulin mesilate 1 mg/2 mL injection, 2 mL vial (Halaven)
10418H OBINUTUZUMAB,
obinutuzumab 1 g/40 mL injection, 40 mL vial (Gazyva)

Alterations

Alteration – Restriction

10418H OBINUTUZUMAB,
obinutuzumab 1 g/40 mL injection, 40 mL vial (Gazyva)

Alteration – Restriction Level

From To
10418H OBINUTUZUMAB,
obinutuzumab 1 g/40 mL injection, 40 mL vial (Gazyva)
authority-required streamlined

Advance Notices

1 February 2019

Deletion – Brand

10158P DBL Docetaxel Concentrated Injection, PFDOCETAXEL, docetaxel 20 mg/2 mL injection, 2 mL vial
7246J DBL Gemcitabine Injection, PFGEMCITABINE, gemcitabine 200 mg/5.3 mL injection, 5.3 mL vial

1 March 2019

Deletion – Brand

7222D Hospira Pty Limited, PFCARBOPLATIN, carboplatin 50 mg/5 mL injection, 5 mL vial
10240Y Arzerra, NVOFATUMUMAB, ofatumumab 100 mg/5 mL injection, 3 x 5 mL vials

Efficient Funding of Chemotherapy (Public Hospital)

Additions

Addition – Item

11543M NIVOLUMAB,
nivolumab 40 mg/4 mL injection, 4 mL vial (Opdivo);
nivolumab 100 mg/10 mL injection, 10 mL vial (Opdivo)

Addition – Brand

4440Q Zavedos Solution, PFIDARUBICIN, idarubicin hydrochloride 5 mg/5 mL injection, 5 mL vial
4440Q Zavedos Solution, PFIDARUBICIN, idarubicin hydrochloride 10 mg/10 mL injection, 10 mL vial
4451G IRINOTECAN ACT, JUIRINOTECAN, irinotecan hydrochloride trihydrate 100 mg/5 mL injection, 5 mL vial

Addition – Caution

2641B IPILIMUMAB,
ipilimumab 50 mg/10 mL injection, 10 mL vial (Yervoy);
ipilimumab 200 mg/40 mL injection, 40 mL vial (Yervoy)

Addition – Restriction

2641B IPILIMUMAB,
ipilimumab 50 mg/10 mL injection, 10 mL vial (Yervoy);
ipilimumab 200 mg/40 mL injection, 40 mL vial (Yervoy)
10745M NIVOLUMAB,
nivolumab 40 mg/4 mL injection, 4 mL vial (Opdivo);
nivolumab 100 mg/10 mL injection, 10 mL vial (Opdivo)

Deletions

Deletion – Brand

4440Q Zavedos Solution, PFIDARUBICIN, IDARUBICIN HYDROCHLORIDE Solution for I.V. injection 5 mg in 5 mL, 3
4440Q Zavedos Solution, PFIDARUBICIN, IDARUBICIN HYDROCHLORIDE Solution for I.V. injection 10 mg in 10 mL, 6

Deletion – Note

10144X ERIBULIN,
eribulin mesilate 1 mg/2 mL injection, 2 mL vial (Halaven)
11212D ERIBULIN,
eribulin mesilate 1 mg/2 mL injection, 2 mL vial (Halaven)
10407R OBINUTUZUMAB,
obinutuzumab 1 g/40 mL injection, 40 mL vial (Gazyva)

Alterations

Alteration – Restriction

10407R OBINUTUZUMAB,
obinutuzumab 1 g/40 mL injection, 40 mL vial (Gazyva)

Alteration – Restriction Level

From To
10407R OBINUTUZUMAB,
obinutuzumab 1 g/40 mL injection, 40 mL vial (Gazyva)
authority-required streamlined

Advance Notices

1 February 2019

Deletion – Brand

10148D DBL Docetaxel Concentrated Injection, PFDOCETAXEL, docetaxel 20 mg/2 mL injection, 2 mL vial
4439P DBL Gemcitabine Injection, PFGEMCITABINE, gemcitabine 200 mg/5.3 mL injection, 5.3 mL vial

1 March 2019

Deletion – Brand

4309T Hospira Pty Limited, PFCARBOPLATIN, carboplatin 50 mg/5 mL injection, 5 mL vial
10249K Arzerra, NVOFATUMUMAB, ofatumumab 100 mg/5 mL injection, 3 x 5 mL vials